Your browser doesn't support javascript.
loading
Molecular classification of hormone receptor-positive HER2-negative breast cancer.
Jin, Xi; Zhou, Yi-Fan; Ma, Ding; Zhao, Shen; Lin, Cai-Jin; Xiao, Yi; Fu, Tong; Liu, Cheng-Lin; Chen, Yi-Yu; Xiao, Wen-Xuan; Liu, Ya-Qing; Chen, Qing-Wang; Yu, Ying; Shi, Le-Ming; Shi, Jin-Xiu; Huang, Wei; Robertson, John F R; Jiang, Yi-Zhou; Shao, Zhi-Ming.
Affiliation
  • Jin X; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhou YF; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Ma D; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhao S; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Lin CJ; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xiao Y; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Fu T; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Liu CL; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Chen YY; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xiao WX; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Liu YQ; State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Chen QW; State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Yu Y; State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Shi LM; State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Shi JX; International Human Phenome Institutes (Shanghai), Shanghai, China.
  • Huang W; Shanghai-MOST Key Laboratory of Health and Disease Genomics, Shanghai Institute for Biomedical and Pharmaceutical Technologies (SIBPT), Shanghai, China.
  • Robertson JFR; Shanghai-MOST Key Laboratory of Health and Disease Genomics, Shanghai Institute for Biomedical and Pharmaceutical Technologies (SIBPT), Shanghai, China.
  • Jiang YZ; University of Nottingham, Royal Derby Hospital, Derby, UK.
  • Shao ZM; Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. yizhoujiang@fudan.edu.cn.
Nat Genet ; 55(10): 1696-1708, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37770634
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Nat Genet Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Nat Genet Year: 2023 Document type: Article